Bridgeway Capital Management’s BioAmber Inc. BIOA Stock Holding History

Bridgeway Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35,000	Closed	-$14K	–	1479
2017 Q4	$14K	Sell	35,000 -166,700	-83%	-$79.3K	﹤0.01%	1383
2017 Q3	$99K	Hold	201,700	–	–	﹤0.01%	1344
2017 Q2	$518K	Hold	201,700	–	–	0.01%	1085
2017 Q1	$468K	Hold	201,700	–	–	0.01%	1091
2016 Q4	$1.11M	Hold	201,700	–	–	0.01%	777
2016 Q3	$855K	Buy	201,700 +125,000	+163%	+$462K	0.01%	868
2016 Q2	$229K	Sell	76,700 -11,480	-13%	-$41.9K	﹤0.01%	1283
2016 Q1	$370K	Buy	88,180 +76,700	+668%	+$322K	0.01%	1156
2015 Q4	$71K	Hold	11,480	–	–	﹤0.01%	1389
2015 Q3	$61K	Hold	11,480	–	–	﹤0.01%	1430
2015 Q2	$99K	Hold	11,480	–	–	﹤0.01%	1429
2015 Q1	$100K	Hold	11,480	–	–	﹤0.01%	1415
2014 Q4	$96K	Sell	11,480 -20,000	-64%	-$182K	﹤0.01%	1394
2014 Q3	$314K	Hold	31,480	–	–	0.01%	1257
2014 Q2	$313K	Buy	31,480 +11,480	+57%	+$119K	0.01%	1243
2014 Q1	$229K	Buy	+20,000	New	+$237K	0.01%	1294

Other funds holding BIOA

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Bridgeway Capital Management's BIOA Position: Q1 2018 in Review

Bridgeway Capital Management sold out of BioAmber Inc. (BIOA) in Q1 2018, closing a stake of 35,000 shares — an estimated $14K sold.

Bridgeway Capital Management first reported a position in BIOA in Q1 2014 and held it in 16 quarters. The position peaked at $1.11M in Q4 2016. 4 funds tracked by Wall St. Rank hold BIOA as of Q1 2018.

Bridgeway Capital Management reported no remaining BioAmber Inc. position as of Q1 2018 after selling out during the quarter.
Bridgeway Capital Management sold 35,000 BioAmber Inc. shares in Q1 2018, an estimated $14K.
Bridgeway Capital Management first reported a position in BioAmber Inc. in Q1 2014 and held it in 16 quarters.
Bridgeway Capital Management's BioAmber Inc. position peaked at $1.11M in Q4 2016.
4 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2018.

Based on Bridgeway Capital Management's 13F filing for Q1 2018, filed 15 May 2018.